Alain Fourquet

Alain Fourquet's AcademicInfluence.com Rankings

Alain Fourquet

Medical

#3343

World Rank

#3811

Historical Rank

Oncology

#234

World Rank

#242

Historical Rank

medical Degrees

Alain Fourquet

Philosophy

#9552

World Rank

#13129

Historical Rank

Logic

#6525

World Rank

#8049

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Alain Fourquet's Degrees

Doctorate Medicine Université Paris Cité
PhD Oncology Université Paris Cité

Why Is Alain Fourquet Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Alain Fourquet's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. (2001) (935)
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. (2015) (812)
Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial (2007) (705)
Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. (1989) (498)
Age as prognostic factor in premenopausal breast carcinoma (1993) (480)
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. (2015) (467)
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. (1994) (438)
Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. (2007) (415)
Infiltrating lobular carcinoma of the breast: Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns (1996) (414)
Male breast cancer (1998) (377)
Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. (1996) (368)
The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. (2000) (323)
Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer (1992) (310)
Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review (2011) (294)
The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. (2012) (265)
Radiation‐induced sarcomas after radiotherapy for breast carcinoma (2005) (231)
Is obesity an independent prognosis factor in woman breast cancer? (2008) (229)
Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast‐conserving surgery and definitive irradiation correlation of pathologic parameters with outcome of treatment (1993) (212)
Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'. (2008) (210)
Long‐term outcome after breast‐conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast (2005) (196)
Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? (2003) (192)
Familial invasive breast cancers: worse outcome related to BRCA1 mutations. (2000) (186)
Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity (2007) (182)
No significant predictive value of c‐ erbB‐2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer (1998) (181)
Contralateral breast cancer: annual incidence and risk parameters. (1995) (177)
Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. (2004) (174)
Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. (1993) (172)
Local control and survival of breast cancer treated by limited surgery followed by irradiation. (1986) (169)
Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast (2008) (165)
Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. (2007) (165)
Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. (2009) (164)
The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. (1999) (164)
BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. (1997) (163)
Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity. (1994) (160)
Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. (2001) (159)
Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems. (1998) (158)
Ten‐year results of breast‐conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast (1991) (155)
KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome (2005) (150)
The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial. (2004) (143)
Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery. (2001) (140)
Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first. (2007) (139)
Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy. (2005) (133)
Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. (2009) (130)
Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review. (2007) (129)
Ophthalmologic and intraocular non‐Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factors (2004) (127)
Second malignancies after breast cancer: the impact of different treatment modalities (2008) (119)
Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925) (2010) (113)
Short and long‐term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial (1999) (112)
Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial (2017) (109)
Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature (2010) (104)
ONCOPOOL - a European database for 16,944 cases of breast cancer. (2010) (103)
The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial. (2008) (101)
Conservative management of intraductal breast carcinoma with tumorectomy and radiation therapy (1986) (100)
Breast radiotherapy in the lateral decubitus position: A technique to prevent lung and heart irradiation. (2005) (100)
Conservative treatment of lower pole breast cancers by bilateral mammoplasty and radiotherapy. (1998) (96)
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial. (2020) (95)
Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy. (2009) (94)
p53 mutation as a genetic trait of typical medullary breast carcinoma. (1999) (94)
Primary breast non‐Hodgkin's lymphoma: A large single center study of initial characteristics, natural history, and prognostic factors (2009) (91)
Survival in early-onset BRCA1 breast-cancer patients (1998) (90)
Postmastectomy radiotherapy: questions for the twenty-first century. (1998) (89)
Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study. (2005) (88)
Circulating macrophage colony stimulating factor as a marker of tumour progression. (2002) (84)
Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age. (2004) (83)
Visualizing chromosomes as transcriptome correlation maps: evidence of chromosomal domains containing co-expressed genes--a study of 130 invasive ductal breast carcinomas. (2005) (80)
Topical superoxide dismutase reduces post‐irradiation breast cancer fibrosis (2004) (80)
Cardiac toxicity in breast cancer patients: from a fractional point of view to a global assessment. (2011) (78)
Conservative treatment of early breast cancer: prognostic value of the ductal in situ component and other pathological variables on local control and survival. Long-term results. (1989) (76)
LMCE3 treatment strategy: results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis. (2000) (76)
Simultaneous bilateral breast carcinomas: a retrospective review of 149 cases. (1994) (75)
CT-scan based localization of the internal mammary chain and supra clavicular nodes for breast cancer radiation therapy planning. (2006) (74)
Single dose versus fractionated total body irradiation before bone marrow transplantation: radiobiological and clinical considerations. (1994) (73)
Postmastectomy electron beam chest wall irradiation in women with breast cancer: a clinical step toward conformal electron therapy. (2007) (72)
Phytoestrogens after breast cancer. (2001) (70)
A prognostic DNA signature for T1T2 node‐negative breast cancer patients (2010) (70)
In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in non-Hodgkin's lymphomas. (1998) (69)
Simultaneous integrated boost in breast conserving treatment of breast cancer: a dosimetric comparison of helical tomotherapy and three-dimensional conformal radiotherapy. (2010) (68)
Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast. (1994) (67)
Can we decrease the skin reaction in breast cancer patients using hyaluronic acid during radiation therapy? Results of phase III randomised trial. (2011) (67)
Search for a Gene Expression Signature of Breast Cancer Local Recurrence in Young Women (2012) (65)
Improving the definition of tumor bed boost with the use of surgical clips and image registration in breast cancer patients. (2010) (64)
Association of Radiotherapy Boost for Ductal Carcinoma In Situ With Local Control After Whole-Breast Radiotherapy (2017) (64)
Preliminary results of whole brain radiotherapy with concurrent trastuzumab for treatment of brain metastases in breast cancer patients. (2011) (64)
How to boost the breast tumor bed? A multidisciplinary approach in eight steps. (2008) (62)
Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial. (2007) (62)
Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: results of a phase II study. (2006) (62)
Iridium-192 versus cobalt-60 boost in 3-7 cm breast cancer treated by irradiation alone: final results of a randomized trial. (1995) (62)
Salvage treatment for local recurrence after breast‐conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast (2001) (61)
Breast cancer in elderly women: a retrospective analysis of combined treatment with tamoxifen and once-weekly irradiation. (1995) (60)
High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers. (2008) (60)
Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma. (2010) (59)
Anatomical, clinical and radiological delineation of target volumes in breast cancer radiotherapy planning: individual variability, questions and answers. (2009) (59)
Radiotherapy for invasive breast cancer: guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence. (2011) (58)
Paget's disease of the nipple without detectable breast tumor: conservative management with radiation therapy. (1987) (58)
Breast irradiation in the lateral decubitus position: technique of the Institut Curie. (1991) (56)
Low expression of bcl-2 in Brca1-associated breast cancers (2000) (56)
ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy. (2000) (55)
Biological and clinical significance of concurrent p53 gene alterations, MDR1 gene expression, and S-phase fraction analyses in breast cancer patients treated with primary chemotherapy or radiotherapy. (1997) (54)
Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience (2009) (54)
Presentation of axillary lymphadenopathy without detectable breast primary (T0 N1b breast cancer): experience at Institut Curie. (1989) (53)
Helical tomotherapy and volumetric modulated arc therapy: New therapeutic arms in the breast cancer radiotherapy. (2016) (51)
Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation. (1996) (50)
Placing the boost in breast-conservation radiotherapy: A review of the role, indications and techniques for breast-boost radiotherapy. (2006) (50)
Histological margin assessment for breast ductal carcinoma in situ: precision and implications (2004) (48)
Simplified rules for everyday delineation of lymph node areas for breast cancer radiotherapy. (2010) (45)
Whole breast radiotherapy in the lateral decubitus position: a dosimetric and clinical solution to decrease the doses to the organs at risk (OAR). (2014) (45)
Familial Breast Cancer: Clinical Response to Induction Chemotherapy or Radiotherapy Related to BRCA1/2 Mutations Status (2009) (44)
Preoperative breast radiation therapy: Indications and perspectives. (2017) (43)
[Standards, Options and Recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004]. (2005) (43)
Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer. (2009) (43)
In vivo induction of apoptosis in human lymphocytes by therapeutic fractionated total body irradiation. (1995) (41)
Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial. (2018) (40)
The acute skin and heart toxicity of a concurrent association of trastuzumab and locoregional breast radiotherapy including internal mammary chain: a single-institution study. (2011) (40)
Concurrent administration of trastuzumab with locoregional breast radiotherapy: long-term results of a prospective study (2014) (38)
Impact of a boost dose of 16 GY on the local control and cosmesis in patients with early breast cancer: The EORTC ‘boost versus no boost’ trial (2000) (38)
EPID based in vivo dosimetry system: clinical experience and results (2016) (37)
Analyzing prognostic factors in breast cancer using a multistate model (1999) (35)
Preoperative radio-chemotherapy in early breast cancer patients: long-term results of a phase II trial. (2012) (35)
Metachronous contralateral breast cancer as first event of relapse. (1996) (35)
Urokinase-type plasminogen activator and plasminogen-activator-inhibitor type 1 predict metastases in good prognosis breast cancer patients. (2009) (34)
Simplified field-in-field technique for a large-scale implementation in breast radiation treatment. (2012) (34)
Whole-brain radiation therapy in breast cancer patients with brain metastases (2010) (34)
Technique alternatives for breast radiation oncology: Conventional radiation therapy to tomotherapy (2009) (34)
Visualisation of the left anterior descending coronary artery on CT images used for breast radiotherapy planning. (2013) (32)
Risks of second malignancies after breast cancer treatment: Long-term results. (2017) (32)
Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodes. (2007) (31)
Prognostic Value of the S‐Phase Fraction of Breast Cancers Treated by Primary Radiotherapy or Neoadjuvant Chemotherapy (1993) (31)
Potential benefits of using cardiac gated images to reduce the dose to the left anterior descending coronary during radiotherapy of left breast and internal mammary nodes. (2012) (31)
Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ. (2005) (30)
Plastic surgery for breast conservation therapy: how to define the volume of the tumor bed for the boost? (2014) (29)
Long-Term Prognostic Performance of Ki67 Rate in Early Stage, pT1-pT2, pN0, Invasive Breast Carcinoma (2013) (29)
Long term outcome of small size invasive breast carcinomas independent from angiogenesis in a series of 685 cases (2001) (29)
Use of deformable image fusion to allow better definition of tumor bed boost volume after oncoplastic breast surgery. (2011) (28)
Is radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy? (2011) (28)
Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage. (2009) (27)
Conservative management of intraductal breast carcinoma with tumorectomy and radiation therapy. (1984) (27)
Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study. (2007) (26)
Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy. (2016) (25)
Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast-conserving surgery? Results of the ARCOSEIN multicenter, Phase III study: patients' and doctors' views. (2007) (25)
Summary version of the standards, options and recommendations for nonmetastatic breast cancer (updated January 2001) (2003) (25)
Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients (2009) (25)
Patient population analysis in EORTC trial 22881/10882 on the role of a booster dose in breast-conserving therapy. (1994) (25)
Longitudinal clinical and functional pulmonary follow-up after megatherapy, fractionated total body irradiation, and autologous bone marrow transplantation for metastatic neuroblastoma. (1999) (24)
Conjunctival low-grade non-Hodgkin's lymphoma: a large single-center study of initial characteristics, natural history and prognostic factors (2006) (24)
Implant breast reconstruction followed by radiotherapy: can helical tomotherapy become a standard irradiation treatment? (2012) (24)
Breat-conserving treatment of ductal carcinoma in situ (1992) (24)
Paget's disease of the nipple without clinically and radiologically detectable breast tumor. Histochemical and immunohistochemical study of 44 cases. (1993) (24)
The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ trial (2004) (23)
Management of inflammatory breast cancer after neoadjuvant chemotherapy. (2011) (23)
[Superoxide dismutase (Cu/Zn) in cutaneous application in the treatment of radiation-induced fibrosis]. (1994) (23)
Medullary breast carcinoma: the role of radiotherapy as primary treatment. (1987) (23)
Effects of superoxide dismutase topical treatment on human skin radiofibrosis: a pathological study (1996) (23)
Combination of Olaparib and radiotherapy for triple negative breast cancer: preliminary results of the RADIOPARP phase I trial. (2020) (22)
Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option. (2010) (22)
S-phase fractions of breast cancer predict overall and post-relapse survival. (1997) (22)
Whole breast radiotherapy in the lateral isocentric lateral decubitus position: Long-term efficacy and toxicity results. (2017) (22)
A parametric regression model of tumor recurrence: An application to the analysis of clinical data on breast cancer (1996) (22)
Management of advanced non‐melanoma skin cancers using helical tomotherapy (2014) (21)
The use of helical tomotherapy in the treatment of early stage breast cancer: indications, tolerance, efficacy—a single center experience (2018) (21)
Helical Tomotherapy for Inoperable Breast Cancer: A New Promising Tool (2013) (21)
Genomic Instability: A Stronger Prognostic Marker Than Proliferation for Early Stage Luminal Breast Carcinomas (2013) (21)
EPID based in vivo dosimetry system: clinical experience and results. (2016) (20)
Concurrent use of palbociclib and radiation therapy: single-centre experience and review of the literature (2020) (20)
Randomized Study Comparing Adjuvant Radiotherapy (RT) with Concomitant Chemotherapy (CT) Versus Sequential Treatment after Conservative Surgery for Patients with Stages I and II Breast Carcinoma: Long-term Results (2002) (20)
Long-Term Results of a Highly Performing Conformal Electron Therapy Technique for Chest Wall Irradiation After Mastectomy. (2017) (20)
High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies (2008) (20)
[Management of malignant phyllodes tumors of the breast: the experience of the Institut Curie]. (2009) (20)
The impact of the loco-regional treatment in elderly breast cancer patients: hypo-fractionated exclusive radiotherapy, single institution long-term results. (2010) (19)
Evolution of radiation techniques in the treatment of breast cancer (BC) patients: From 3D conformal radiotherapy (3D CRT) to intensity-modulated RT (IMRT) using Helical Tomotherapy (HT). (2017) (19)
Should We Move Beyond Mean Heart Dose? (2020) (19)
Combination of radiotherapy and double blockade HER2 with pertuzumab and trastuzumab for HER2-positive metastatic or locally recurrent unresectable and/or metastatic breast cancer: Assessment of early toxicity. (2017) (19)
Place of modern imaging modalities for solitary plasmacytoma: toward improved primary staging and treatment monitoring. (2012) (18)
Factors associated with patient-reported cosmetic outcome in the Young Boost Breast Trial. (2016) (18)
Lack of HIN-1 Methylation Defines Specific Breast Tumor Subtypes Including Medullary Carcinoma of the Breast and BRCA1-Linked Tumors (2003) (17)
Responses to concurrent radiotherapy and hormone-therapy and outcome for large breast cancers in post-menopausal women. (2007) (17)
Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment (2009) (17)
Side-ffects 15 Years after Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925. (2021) (17)
Effects of low dose total body irradiation (LDTBI) and recombinant human interleukin-2 in mice. (1993) (16)
1076 Influence of surgery-radiotherapy interval on recurrence in breast-conserving treatment of small breast cancer (1995) (16)
A radiotherapy contouring atlas for cardiac conduction node delineation. (2021) (16)
Comparative image and flow cytometric TUNEL analysis of fine needle samples of breast carcinoma. (2001) (16)
Breast radiotherapy in women with pectus excavatum (funnel chest): is the lateral decubitus technique an answer? A dosimetric study. (2006) (16)
[Primary epidermoid carcinoma of the breast. Clinical, histopathologic and prognostic study of 14 patients]. (1992) (16)
MANAGEMENT OF BREAST CANCER IN THE ELDERLY (1988) (16)
High Ki67 expression is a risk marker of invasive relapse for classical lobular carcinoma in situ patients. (2012) (15)
Prognostic significance of clinical nodal involvement in patients treated by radical radiotherapy for a locally advanced breast cancer (1984) (15)
Solitary plasmocytoma: improvement in critical organs sparing by means of helical tomotherapy (2009) (15)
The Limits of the Linear Quadratic (LQ) Model for Late Cardiotoxicity Prediction: Example of Hypofractionated Rotational Intensity Modulated Radiation Therapy (IMRT) for Breast Cancer. (2020) (15)
Medullary breast carcinoma: prognostic implications of p53 expression. (2003) (15)
Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery (2016) (14)
OC-0523: Lymph node RT improves survival in breast cancer: 10 years results of the EORTC ROG and BCG phase III trial 22922/10925. (2014) (14)
In vitro radiation-induced apoptosis and tumour response to radiotherapy: a prospective study in patients with non-Hodgkin lymphomas treated by low-dose irradiation. (1997) (14)
Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial. (2015) (14)
Combination of Olaparib with radiotherapy for triple‐negative breast cancers: One‐year toxicity report of the RADIOPARP Phase I trial (2021) (14)
Fifteen-year results of the randomised EORTC trial 22922/10925 investigating internal mammary and medial supraclavicular (IM-MS) lymph node irradiation in stage I-III breast cancer. (2018) (14)
The Impact of Boost Dose and Margins on the Local Recurrence Rate in Breast Conserving Therapy: Results From the EORTC Boost-No Boost Trial (2007) (13)
[Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer]. (2014) (13)
[Radiotherapy of invasive breast cancer: French national guidelines]. (2012) (13)
[Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects]. (2004) (13)
[Protontherapy: basis, indications and new technologies]. (2010) (13)
[Controversy about internal mammary chain irradiation in breast cancer]. (2014) (13)
Outcomes of postoperative radiation therapy for breast cancer in older women according to age and comorbidity status: An observational retrospective study in 752 patients. (2018) (12)
Adjuvant Trastuzumab Emtansine (T-DM1) and Concurrent Radiotherapy for Residual Invasive HER2-positive Breast Cancer (2020) (12)
Disseminated Tumor Cells Predict Efficacy of Regional Nodal Irradiation in Early Stage Breast Cancer. (2019) (12)
Corrigendum to “Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first” [Radiother Oncol 82 (2007) 272–280] (2007) (12)
[Radiotherapy of breast cancer]. (2002) (11)
Optimization and auto-segmentation of a high risk cardiac zone for heart sparing in breast cancer radiotherapy. (2020) (11)
Photons Without Bolus Versus Electrons With Bolus After Upfront Mastectomy Without Immediate Reconstruction in Breast Cancer Patients. (2019) (10)
Validation over time of a nomogram including HER2 status to predict the sentinel node positivity in early breast carcinoma. (2012) (10)
[Radiotherapy for breast cancer and pacemaker]. (2011) (10)
Epigenomic Alterations in Breast Carcinoma from Primary Tumor to Locoregional Recurrences (2014) (10)
[Thyroid cancer. A multidimensional analysis of prognostic factors]. (1983) (10)
[Radiotherapy for breast cancer: respiratory and set-up uncertainties]. (2005) (10)
[French national evaluation for helicoidal tomotherapy: description of indications, dose constraints and set-up margins]. (2007) (10)
The fibroblast growth factor receptor 1 (FGFR1), a marker of response to chemoradiotherapy in breast cancer? (2012) (10)
Clinical practice of breast cancer protontherapy: A single-centre experience from selection to treatment. (2021) (9)
Twelve years of experience of breast cancer at the Institut Curie: improvement of survival and value of screening mammographics (1997) (9)
Patterns of loco regional failure in women with breast cancer treated by Postmastectomy Conformal Electron Beam Radiation Therapy (PMERT): Large scale single center experience (2017) (9)
[Phytoestrogens in the contraindication of hormone replacement therapy. The problem of breast cancer]. (2000) (8)
Can we Reduce the Toxicity of the Mediastinal Irradiation Using New Highly Conformal Techniques (2014) (8)
[Breast radiation therapy during COVID-19 outbreak: Practical advice]. (2020) (8)
Cardiac substructure exposure in breast radiotherapy: a comparison between intensity modulated proton therapy and volumetric modulated arc therapy (2021) (8)
Cancer controlatéral du sein : métastase ou second cancer primitif ? (1996) (8)
Progressive inflammatory breast cancer in patient receiving chemotherapy: the importance of radiotherapy as a part of locoregional treatment. (2009) (8)
[PARP inhibitors and radiotherapy: rational and prospects for a clinical use]. (2014) (8)
Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancer. (2015) (8)
Testing the Independence of Competing Risks: An Application to the Analysis of Breast Cancer Recurrence (1994) (8)
6N Irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer: state of the day of EORTC phase III trial 22922/10925 with 4004 patients (2010) (8)
Breast cancer in premenopausal women : Is young age at diagnosis an independant prognostic factor? (1992) (8)
[Breast-conserving therapy of breast cancer]. (2004) (8)
Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer. (2014) (7)
[Monocentric evaluation of the skin and cardiac toxicities of the concomitant administration of trastuzumab and radiotherapy]. (2009) (7)
Preoperative radiation therapy: The 'new' targeted breast cancer treatment? (2017) (7)
Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients (2009) (7)
Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study (2019) (7)
Pertuzumab and Trastuzumab Combination with Concomitant Locoregional Radiotherapy for the Treatment of Breast Cancers with HER2 Receptor Overexpression (2021) (7)
Intraductal carcinoma of the breast: Long-term results with breast-conserving surgery and definitive irradiation (1993) (7)
The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology. (2018) (7)
Feasibility of helical tomotherapy for debulking irradiation before stem cell transplantation in malignant lymphoma. (2011) (7)
[Paget's disease of the nipple without any associated mammary tumor clinically or radiologically detectable. Apropos of 51 cases treated at the Curie Institute]. (1987) (7)
Use of helical tomotherapy in locally advanced and/or metastatic breast cancer for locoregional treatment. (2018) (6)
A case-control study to identify molecular risk factors for local recurrence in young breast cancer patients. (2020) (6)
[Ductal carcinoma in situ of the breast (DCIS). Histopathological features and treatment modalities: analysis of 1,289 cases]. (2010) (6)
The place of the boost in the breast cancer treatment: State of art. (2022) (6)
Preliminary experience of whole-brain radiation therapy (WBRT) in breast cancer patients with brain metastases previously treated with bevacizumab-based chemotherapy (2011) (6)
[Contralateral breast cancer: metastasis or second primary cancer?]. (1996) (6)
The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: results from the EORTC 22922/10925 randomised trial. (2022) (6)
Assessment of a conventional volumetric-modulated arc therapy knowledge-based planning model applied to the new Halcyon© O-ring linac in locoregional breast cancer radiotherapy. (2021) (6)
[Radiation-induced sarcomas after breast cancer: experience of Institute Curie and review of literature]. (2006) (6)
The role of helical tomotherapy in the treatment of bone plasmacytoma. (2012) (6)
Prospective and Comparative Evaluation of the Toxicity of Adjuvant Concurrent Chemoradiotherapy After Neoadjuvant Chemotherapy for Breast Cancer (2013) (5)
[Stoutness and prognosis of female non-metastatic breast cancer: results from a French observational cohort study]. (2009) (5)
Are ipsilateral breast tumour invasive recurrences in young (⩽40 years) women more aggressive than their primary tumours? (2007) (5)
Severe acute radiation-related skin toxicity in a breast cancer patient with Behçet's disease. (2009) (5)
[Concurrent radiation therapy and dual HER2 blockade in breast cancer: Assessment of toxicity]. (2021) (5)
Dosimetric comparison of four high performance techniques for irradiation of breast cancer patients. (2021) (5)
Radiation dose homogeneity in an EORTC multicenter trial on breast irradiation. (1999) (5)
Sequence of radiotherapy and chemotherapy after breast-conserving surgery in small invasive breast cancer (2000) (5)
Out-of-hospital follow-up after low risk breast cancer within a care network: 14-year results. (2014) (5)
Helical tomotherapy and systemic targeted therapies in solitary plasmacytoma: Pilot study. (2013) (5)
[Definition of nodal volumes in breast cancer treatment and segmentation guidelines]. (2009) (5)
[Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities]. (2006) (5)
Risk of second non breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving treatment (2006) (4)
P4-17-02: Whole-Brain Radiation Therapy Plus Concomitant Temozolomide for the Treatment of Brain Metastases from Breast Cancer: A Randomized Prospective Multicenter Phase II Study. (2011) (4)
Development of simplified auto-segmentable functional cardiac atlas. (2022) (4)
Multicentre combined chemotherapy protocol for large cell advanced non hodgkin's lymphoma (2006) (4)
Left Breast Cancer Treated in Isocentric Lateral Decubitus (ILD) Position: An Alternative Technique Sparing Organs at Risk (OAR) (2013) (4)
Radioparp: A phase I of olaparib with radiation therapy (RT) in patients with inflammatory, locoregionally advanced or metastatic triple-negative breast cancer (TNBC) or patient with operated TNBC with residual disease—Preliminary results. (2020) (4)
[Meta-analyses of the effects of radiotherapy in breast cancer: the ultimate evidence?]. (2008) (4)
Prognostic factors for local recurrence following breast-conserving treatment in young women (2010) (4)
The impact of isolated local recurrence on long-term outcome in early-breast cancer patients after breast-conserving therapy. (2021) (4)
Impact of the boost dose on local control and survival in patients with early stage breast cancer after a microscopically incomplete lumpectomy : 10 years results of the randomised EORTC boost trial 22881/10882. (2006) (4)
6LBA The benefit of regional irradiation in stage I–III breast cancer: 10 years results of the EORTC ROG and BCG phase III trial 22922/10925 (2014) (4)
Concurrent use of aromatase inhibitors and hypofractionated radiation therapy. (2012) (4)
Significance of margins of excision on breast cancer recurrence (on behalf of the EORTC Radiotherapy, Breast Cancer Groups) (2004) (4)
Benefit of Post Mastectomy Radiation Therapy (PMRT) in Node-Positive, HER2-Positive Patients With Breast Cancer Receiving Anti-HER2 Treatments. (2020) (4)
Combination of Modern Radiotherapy and New Targeted Treatments for Breast Cancer Management (2021) (4)
[Shared responsibility for follow-up of breast cancer patients. Experience of the Institut Curie]. (2008) (4)
Long-Term Prognostic Performance of Ki 67 Rate in Early Stage , pT 1pT 2 , pN 0 , Invasive Breast Carcinoma (2013) (4)
Risk of Second Non Breast Malignancies (SNBM) in Relation to Brca1 And Brca2 Mutation Status Following Breast-Conserving Surgery and Radiotherapy (2006) (4)
[High risk of cardiac dysfunction after treatment of secondary acute myeloid leukemia following chemotherapy and radiotherapy for breast cancer]. (2010) (3)
Long-term follow-up results of intensity-modulated radiotherapy with helicoïdal tomotherapy for non-metastatic breast cancers: Single centre experience. (2022) (3)
Radiation Boost for Ductal Carcinoma In Situ After Whole-Breast Radiation Therapy (WBRT) Improves Local Control: Analysis From 10 Pooled Academic Institutions (2016) (3)
Abstract 87: Micropapillary breast carcinoma is characterized by deregulation of genes involved in cell division control (2012) (3)
Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer: The Phase 1 Olaparib and Radiation Therapy for Triple-Negative Breast Cancer Trial. (2022) (3)
Local and distant relapses in relation to age following breast-conserving surgery and irradiation in premenopausal patients with breast cancer (1998) (3)
[Histological margin and residual disease assessment for breast carcinoma]. (2003) (3)
[Management of inflammatory breast cancer after neo-adjuvant chemotherapy]. (2011) (3)
The higher local recurrence rate after breast conserving therapy in young patients explained by larger tumor size and incomplete excision at first attempt (1998) (3)
Abstract 4428: Pre-clinical studies of the therpaeutic effect of a PARP inhibitor combined with radiotherapy for breast cancer treatment. (2013) (3)
No Evidence of Increased Skin Toxicity with Aromatase Inhibitors and Concurrent Hypofractionated Radiation Therapy in Menopausal Breast Cancer Patients (2010) (3)
[Breast cancer follow-up by primary care physician: patient satisfaction in the Metropolitan Paris region]. (2012) (3)
Patterns of locoregional failure in women with early-stage breast cancer treated by whole breast irradiation in the lateral isocentric decubitus position: Large-scale single-centre experience. (2019) (3)
[Concurrent whole-brain radiotherapy with trastuzumab for treatment of brain metastases in breast cancer patients: questions and answers]. (2011) (2)
The 1951-98 experience of the Paris Institut Curie Radiopathology Unit: a preliminary report (1999) (2)
142 Role of metachronous contralateral breast carcinoma in the outcome of breast cancer (1995) (2)
[Radiotherapy of cancer of the breast. Technical problems and new approaches]. (2000) (2)
[Intraductal cancer of the breast in women under age 35 years]. (1996) (2)
Paget's disease of the nipple : Conservative management with radiation therapy (1986) (2)
Cardiac radiation-induced sarcomas: A SEER population-based study and a literature review. (2020) (2)
Helical tomotherapy for patients presented with implant breast reconstruction in case of adjuvant breast cancer radiotherapy: A single center experience (2019) (2)
Institut Curie guidelines on breast target volume delineation for patients treated in lateral position. (2020) (2)
[Hypofractionated breast radiotherapy in 13 fractions, perfect tolerance or delayed early reaction? Prospective study of Curie Institute]. (2009) (2)
[Ductal carcinoma in situ diagnosis: 3 French national guidelines]. (2016) (2)
Salvage treatment for recurrence in the breast following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast (1993) (2)
Tolerance of concurrent CDK inhibitor and radiation therapy in metastatic breast cancer patients. (2020) (2)
Outcome and prognostic factors of isolated breast recurrences in patients treated with breast-conserving surgery and radiotherapy for early breast cancer (2003) (2)
PP-3-7 Long term time course of breast recurrence after breast-conservative treatment of small breast cancer (1996) (2)
[Early stage breast cancer: is exclusive radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?]. (2011) (2)
Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers (2007) (2)
[Breast cancer without palpable tumor revealed by microcalcifications. Prognosis and treatment]. (1995) (2)
A Therapeutic Challenge: Chemo-refractory Non-metastatic Inflammatory Breast Cancers (2022) (2)
Salvage treatment for local recurrence after breast-conserving surgery followed by radiation as initial treatment for mammographically-detected ductal carcinoma in situ of the breast (2004) (2)
The impact of a boost dose on the local recurrence rate in high risk patients after breast conserving therapy – results from the EORTC boost-no boost trial (2008) (2)
[Prospective monocentric study of the toxicity and the efficacy of concurrent trastuzumab and radiotherapy]. (2013) (2)
[Radiation-induced retinopathy]. (2002) (2)
T-Cell Infiltrate After Monoclonal Anti-CD20 Antibody Therapy for B-Cell Lymphoma (2000) (2)
["Standards, Options and Recommendations 2001" for radiotherapy in patients with non-metastatic infiltrating breast cancer. Update. National Federation of Cancer Campaign Centers (FNCLCC)]. (2002) (2)
O-62 External validation in ONCOPOOL of updated survival according to the Nottingham Prognostic Index (NPI) (2007) (2)
[Concomitant association of radiotherapy and chemotherapy in inflammatory breast cancer. Initial results of phase II trial]. (1991) (2)
Medullary Breast Carcinoma: Prognostic Implications of P53 Expression (2003) (2)
Breast reconstruction after breast-cancer surgery. (2009) (2)
Evaluation of Cardiac Conduction System Exposure with Breast Volumetric Modulated Arc Therapy and Intensity Modulated Proton Therapy. (2021) (1)
Superoxide dismutase content of breast carcinoma: lack of relationship with radiosensitivity. (1986) (1)
Evaluation of the early adverse effects of radiotherapy in breast cancer patients with COVID‐19: Prospective single institutional study (2021) (1)
Abstract OT3-04-01: A phase I of olaparib with radiation therapy in patients with inflammatory, loco-regionally advanced or metastatic TNBC (triple negative breast cancer) or patient with operated TNBC with residual disease (2018) (1)
Is Exclusive Radiotherapy an Option for Early Breast Cancers with Complete Clinical Response after Neoadjuvant Chemotherapy (2009) (1)
Immobilization System and Set-up Variability of Patients with Large Pendulous Breasts Treated in the Lateral Decubitus Position (2011) (1)
Corrigendum to “ONCOPOOL – A European database for 16,944 cases of breast cancer” [European Journal of Cancer 46 (2009) 56–71] (2010) (1)
Pattern of relapse in low‐risk breast cancer patients followed within a community care network (2017) (1)
Can We Consider Always an Esophageal Carcinoma as Radiation Associated Cancer After Irradiation for Breast Cancer? (2009) (1)
Corrigendum to “Iridium-192 versus cobalt-60 boost in 3–7 cm breast cancer treated by irradiation alone: final result of a randomized trial” (1995) (1)
1BA The impact of pathological factors on long-term local control in the EORTC boost no-boost trial (2015) (1)
Recent advances in breast cancer radiotherapy (2008) (1)
[Value of granisetron in the prevention of digestive disorders in total body irradiation]. (1994) (1)
183 A DNA signature to identify high-risk small node-negative breast cancer patients (2010) (1)
Radiotherapy in the Management of Non-Metastatic Inflammatory Breast Cancers: A Retrospective Observational Study (2021) (1)
Concurrent use of palbociclib and radiation therapy: single-centre experience and review of the literature (2020) (1)
Deep Inspiration Breath-Hold (DIBH) for Locoregional Breast Irradiation using Volumetric Modulated Arc Therapy (VMAT) and Intensity Modulated Proton Therapy (IMPT): A Dosimetric Comparison to Cardiac Substructure (2020) (1)
[Long follow-up of breast cancer revealed by clustered microcalcifications without palpable mass]. (2004) (1)
[Hypofractionated whole breast irradiation: Pro and cons]. (2011) (1)
Does Semi-Quantitative Evaluation Improve the Prognostic Value of Histological Grade in Breast Carcinoma: Comparison of Scarff-Bloom-Richardson (SBR) and Elston-Ellis (EE) Grading Systems in a Series of 825 Cases with a Follow-Up of 10 Years (1996) (1)
Craniospinal Irradiation (CSI) in Acute Lymphoblastic Leukemia: Comparison between Conformal Radiotherapy, Intensity-Modulated Radiotherapy, and Helical Tomotherapy (HT) (2012) (1)
Optimal management of breast cancer with locoregional radiotherapy (2005) (1)
31 Brachytherapy boost parameters and local recurrence in breast cancer patients treated with conservative surgery and radiotherapy (2001) (1)
Evaluation of a software for automatic delineation of the mammary gland and organs at risk in patients treated for breast cancer in lateral position. (2020) (1)
Recurrent breast carcinoma after conservative treatment: MRI features and pathologic correlation (1994) (1)
[Standards, options and recommendations for the management of patients with infiltrating non metastatic breast cancer (2nd edition, 2001)--summary version]. (2003) (1)
128 Locoregional recurrences in triple-negative, node-negative early stage breast cancer treated with breast-conserving treatment (2010) (1)
Abstract P3-12-16: Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial (2016) (1)
Abstract P5-21-03: Concurrent loco-regional radiotherapy and trastuzumab in early-stage breast cancer: Long term results of prospective single-institution study (2012) (1)
Can we treat with radiation breast cancer patients with covid-19 infection? Results from a prospective study (2022) (1)
OC-0488: 17 year results of the randomized boost versus no boost EORTC 22881-10882 trial in early breast cancer (2014) (1)
Abstract OT2-03-01: A phase one trial of olaparib with radiation therapy in patients with triple negative breast cancer: RADIOPARP (2020) (1)
Whole Brain Radiotherapy with Concurrent Trastuzumab for Treatment of Brain Metastases in Breast Cancer Patients (2010) (1)
How to Boost the Breast Tumor Bed? The Procedure Description Step by Step in 8 Phases (2007) (1)
Unusual severe radiation-induced toxicity in a patient with discoid lupus erythematosus: A case report and critical review of the literature. (2021) (1)
2027 ORAL Predictors of increased risk of breast fibrosis at 10 years with higher radiation dose in the early breast cancer (EORTC “Boost versus no Boost” trial 22881–10882). (2007) (1)
[Locoregional control and patterns of locoregional failure in women with breast cancer treated by highly conformal electron beam irradiation]. (2019) (1)
Neoadjuvant Concurrent Radiotherapy and Chemotherapy in Early Breast Cancer Patients: Long-Term Results of a Prospective Phase II Trial (2021) (1)
Cardiotoxicity of the Association Trastuzumab–Locoregional Breast Radiation Therapy: A Prospective Monocentric Study (2013) (1)
[Adjuvant irradiation in breast cancer patients with ATM gene heterozygous mutations: special focus on clinical efficacy/toxicity]. (2009) (1)
Scleroderma and radiotherapy as part of the treatment of breast carcinoma: Six cases and a short critical review of the literature (2007) (1)
Predictors of local control following radiotherapy alone for breast cancer (1991) (1)
Can Helical Tomotherapy be used as a Safe Treatment Alternative for Breast Cancer Patients (2012) (1)
Patient population comparison between EORTC randomized trials 22922/10925 investigating internal mammary and medial supraclavicular (IM-MS) lymph node irradiation and 22881/10882 investigating the role of a boost in BCT (2005) (1)
Postmastectomy Electron Beam Radiation Therapy (PMERT): Efficacy and Toxicity (2016) (1)
Hyaluronic Acid vs. Simple Emollient for the Management of Radio-induced Early Skin Toxicity: Results of an Open-label, Phase III Trial (2010) (1)
European Society for Therapeutic Radiology and Oncology (ESTRO) teaching course and workshop E6. Recent advances in breast cancer radiotherapy (2008) (1)
Prospective and Comparative Evaluation of the Toxicity of Adjuvant Concurrent Chemo-radiotherapy after Neoadjuvant Chemotherapy for Breast Cancer (2011) (1)
Helical Tomotherapy for Debulking Irradiation Prior to Stem Cells Transplantation in Malignant Lymphoma (2009) (1)
Long-term results of a phase II trial of preoperative concurrent radiochemotherapy for breast cancers. (2010) (1)
Dose received by the sentinel lymph node (SLN) clip – prospective comparative study of two radiotherapy (RT) techniques of breast irradiation (2008) (0)
Radiotherapy in early breast cancer (2006) (0)
Management of localized primary breast B-cell Non-Hodgkin's Lymphoma: Role of CNS prophylaxis. (2004) (0)
[Cancers of the breast. Primary non-surgical treatments of so-called "operable" cancers of the breast]. (1995) (0)
Assessment of Side Effects of Radiation Therapy in Patients With COVID-19 Treated for Early-Stage Breast Cancer (2021) (0)
103 Breast conserving surgery following primary irradiation in 3–7 cm breast cancer: Pathologic response and outcome (1997) (0)
[Theory and practice of locoregional treatment in cancers of the breast]. (1992) (0)
463 Concurrent Radiotherapy and Trastuzumab in Early-stage Breast Cancer – A Prospective Single Institutional Experience (2012) (0)
99 Concurrent whole brain radiotherapy (WBRT) and trastuzumab (T) in breast cancer (BC) patients presenting with brain metastases (2010) (0)
Long-Term Survival and Toxicity in Patients Treated With Radiotherapy for Neuroendocrine Breast Cancer: A Single-Center Experience. (2021) (0)
Optimal Boost to Breast Tumor Bed: How to use the Clips and Initial Tumor Site? (2009) (0)
357 Tolerance of concurrent adjuvant trastuzumab and radiotherapy, involving in most cases the internal mammary chain, for breast cancer: results from a prospective study (2010) (0)
OP-JNCI210114 1360..1368 (2021) (0)
Genomic and transcriptomic differences between lobular and luminal ductal invasive carcinoma. (2009) (0)
[Standards, Options and Recommendations (SOR) for endocrine therapy in patients with non metastatic breast cancer. FNCLCC]. (2000) (0)
EP-2122 Outcome of exclusive RT for BC in older women according to age and comorbidity: A retrospective study (2019) (0)
Randomized Phase 2 Study of Whole-Brain Radiation Therapy With or Without Concomitant Temozolomide for Brain Metastases From Breast Cancer (2014) (0)
PO-0677: Rotational intensity Modulated Radiation Therapy in complex adjuvant breast and nodes irradiation (2015) (0)
Second Malignancies After Breast Cancer Treatment and Their Relationship With Adjuvant Radiation Therapy: Long-term Results (2012) (0)
Tumour Aromatase Expression, a Prognostic for Local Control in Young Breast Cancer Patients after Breast-Conserving Treatment? (2009) (0)
Clinical outcomes of curative-intent multimodal management of chemorefractory nonmetastatic inflammatory breast cancer (2022) (0)
Conservative treatment of breast cancer: When, how, and who? (1997) (0)
Craniospinal Irradiation in Hematological Malignancies: Can the Helical Tomotherapy Become a Standard? (2011) (0)
Bone marrow disseminated tumor cells, loco-regional and adjuvant treatment are prognostic factors for loco-regional relapses in early breast cancers. (2009) (0)
Breast cancer in premenopausal women/should mastectomy be recommended? (1998) (0)
PO-1088 Cardiac conduction system exposure during breast radiotherapy : evaluation of IMRT and protontherapy (2021) (0)
E6. Radiotherapy in breast cancer (2002) (0)
PD-0739 Neoadjuvant chemo-radiotherapy in early breast cancer patients:long-term results of a phase II trial (2022) (0)
DCIS with close or focally involved margins following breast-conserving surgery (BCS): reexcision or radiotherapy with boost? (2008) (0)
EP-1165: Short and long term safety of a post-mastectomy conformal electron beam radiotherapy (PMERT) (2017) (0)
Radiotherapy in the Treatment of Solitary Plasmacytoma: New Technical Approaches and New Indications (2009) (0)
PD02-08: Validation over Time of a Nomogram Predicting the Sentinel Node Positivity in Early Breast Carcinoma According to the Molecular Subtypes Classification. (2011) (0)
Multidisciplinary management of patients with BRCA1 and BRCA2 mutations in institut Curie of paris (2006) (0)
Anatomical, clinical and radiological delineation of target volumes in the radiotherapy planning of breast cancer: individual variability, questions and answers (2008) (0)
Five‐year outcomes in patients treated with surgery and radiotherapy for primary neuroendocrine neoplasm of the breast (2021) (0)
769 poster POTENTIAL BENEFITS OF USING CARDIAC GATED IMAGES TO REDUCE THE DOSE TO THE LEFT ANTERIOR DESCENDING CORONARY DURING RADIOTHERAPY OF LEFT BREAST AND INTERNAL MAMMARY NODES (2011) (0)
How to Boost the Breast Tumor Bed After Oncoplastic Surgical Procedure Using Surgical Clips and Image Registration (2012) (0)
Patterns of loco-regional failure in women with early stage breast cancer treated by whole breast radiotherapy in lateral position: Large scale single center experience (2018) (0)
Acquis et limites en sénologie / Assets and limits in breast diseases (2013) (0)
Standards, Options and Recommendations for endocrine therapy in patientswith non metastatic breast cancer (2000) (0)
Dosimetric evaluation of the benefit of deep inspiration breath hold (DIBH) for locoregional irradiation of right breast cancer with volumetric modulated arctherapy (VMAT) (2023) (0)
EP-2388: Use of helical tomotherapy for local treatment in metastatic breast cancer: single center experience (2018) (0)
One-Year Toxicity Report of the RADIOPARP Phase I Trial Evaluating Olaparib With Radiotherapy for Triple Negative Breast Cancer. (2021) (0)
Safety and tolerability of olaparib combined with breast radiotherapy in patients with triple-negative breast cancer: Final results of the RADIOPARP phase 1 trial. (2022) (0)
775 Impact of BRCA2 Mutation in Primary Human Triple Negative Breast Cancer Xenografts on the Responses to Ionizing Radiation and in Vivo Tumor Growth after Treatment (2012) (0)
Abstract P2-11-20: Tolerability and outcomes of radiation therapy for breast cancer in older women: A retrospective study in 817 patients (2018) (0)
114 Validation process of a gene-expression signature of local recurrences after breast-conserving treatments (2010) (0)
[Treatment of intraductal breast cancers: results, role of radiotherapy]. (1990) (0)
PO-0761 Hypofractionated whole breast irradiation safety after breast-conserving surgery for young patients (2019) (0)
Pathological assessment after neoadjuvant therapy: not an easy task (2008) (0)
PO-0655: Patterns of locorégional failure in women with breast cancer treated by Postmastectomy Radiotherapy (2017) (0)
Évaluation nationale delatomothérapie hélicoïdale: description desindications, descontraintes dedose etdesseuils derepositionnement (2007) (0)
Abstract P3-19-14: Development of simplified auto-segmentable functional cardiac atlas (2022) (0)
The influence of the boost on the cosmetic outcome after breast conserving therapy (1998) (0)
1317 poster DOSE RATE ISSUES IN TOTAL BODY IRRADIATION DELIVERED WITH HELICAL TOMOTHERAPY (2011) (0)
Risk of breast recurrence in relation to BRCA1/2 mutation status following breast-conserving surgery and radiotherapy (2004) (0)
Multidisciplinary management and role of reirradiation in the treatment of a breast cancer patient with four locoregional recurrences. (2022) (0)
Breast Non Hodgkin’s Lymphoma (NHL): A Large Monocentric Study of Initial Characteristics, Natural History, and Prognostic Factors. (2004) (0)
Corrigendum to "A case-control study to identify molecular risk factors for local recurrence in young breast cancer patients" [Radiother Oncol 156 (2021) 127-135]. (2021) (0)
Long-term Follow-up for Inflammatory Breast Cancer Patients: Institute Curie Experience (2010) (0)
PO-1089 Long-term follow-up of a single-center neuroendocrine breast cancer cohort (2021) (0)
[Breast conserving surgery in locoregional treatment of breast carcinoma after Hodgkin lymphoma]. (2012) (0)
Pathological response to preoperative concurrent chemoradiotherapy for breast cancers considered too large for initial conserving surgery: results of a phase II study (2006) (0)
Timing of radiotherapy and chemotherapy (2004) (0)
451 Locoregional treatment of inflammatory breast cancer after neoadjuvant chemotherapy (2010) (0)
379 Hyaluronic acid versus simple emollient for the management of radio-induced skin toxicity: results of an open-label, phase III trial (2010) (0)
BRCA1Sequence Variations in160Individuals Referred toa Breast/ Ovarian Family CancerClinic (1997) (0)
Value and indications of surgery in locally advanced breast cancers (1997) (0)
Visualization of the Left Anterior Descending Coronary Artery on Computed Tomographic Images Used for the Planning of Breast Radiation Treatments (2012) (0)
Abstract P2-11-08: Risk factors for fibrosis after whole breast radiation therapy in lateral position : A large scale single center experience (2018) (0)
Primary C hemotherapy f or O perable B reast C ancer: Incidence a nd P rognostic S ignificance o f I psilateral B reast Tumor R ecurrence A fter B reast-Conservin g S urgery (2001) (0)
Timing of combined chemoradiotherapy in the conservative treatment of locally advanced breast cancer (LABC) (1998) (0)
113 Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long term results and review of the literature (2010) (0)
PO-0967: Toxicity of concurrent Palbociclib and Radiation therapy in metastatic breast cancer patients (2020) (0)
Abstract P1-10-16: Cardiac conduction system exposure with modern radiotherapy techniques for breast cancer irradiation (2023) (0)
OC-0159: Disseminated tumor cells as factor of benefit of regional lymph nodes irradiation in breast cancer (2018) (0)
Abstract P1-10-17: Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer (2017) (0)
410 Lobular and luminal ductal invasive carcinoma of the breast – comparative molecular analysis (2010) (0)
Axillary nodal irradiation in breast cancer: When and how? (1995) (0)
Medullary breast carcinoma. Ten-year results in 108 patients treated in a single center (1998) (0)
Long-term results and comparative analysis of normo fractionated (NF) and hypo fractionated (HF) adjuvant radiotherapy after breast conserving surgery in elderly (2008) (0)
Long-term Results and Comparative Analysis of Adjuvant Radiotherapy after Breast Conserving Surgery in Elderly: Normo Fractionated (nf) and Hypo Fractionated (hf) (2008) (0)
Abstract P4-12-05: A retrospective study of 27 patients with ER-positive, HER2 negative metastatic breast cancer treated with concomitant palbociclib and radiation therapy (2020) (0)
DCIS Update: Escalation or De-escalation? Boost, Fractionation, and Omission of Radiation. (2023) (0)
In Reply to Khosla et al. (2019) (0)
Concurrent Use of Radiation Therapy and Targeted Molecules in the Breast Cancer Treatment (2017) (0)
Does prior pregnancy influence breast cancer outcome in young women (1998) (0)
Impact on the cosmetic outcome of concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery: Differences between patient’s and doctor’s views (2006) (0)
PO-1849: Evaluation of an automatic contouring software in breast cancer treated in lateral position (2020) (0)
P04 Neuroblastoks stude IV chez des enfants is plus de un as: Resultats perlfuxires de l'etude lucky 5 100 patients non selectiones (1995) (0)
E14. New techniques in radiotherapy of breast cancer (2014) (0)
761 poster IMPLANT BREAST RECONSTRUCTION FOLLOWED BY RADIOTHERAPY: CAN THE TOMOTHERAPY BECOME A STANDARD OF IRRADIATION? (2011) (0)
RADIOPARP: A Phase I of Olaparib with Radiation Therapy (RT) in Patients with Inflammatory, Loco-regionally Advanced or Metastatic TNBC (Triple Negative Breast Cancer) or Patient with Operated TNBC with Residual Disease (2020) (0)
[Normofractionated breast irradiation in breast cancer. Indications and benefits]. (2016) (0)
Radiation therapy after breast-conserving surgery (2012) (0)
The use of the BCT in the population included in the EORTC22922/10925 investigating elective lymph node irradiation comparing with 22881/10882 investigating the role of a boost in early breast cancer (2006) (0)
CT-scan Based Localization of the Internal Mammary Chain (IMC) and Supra Clavicular Nodes (SCN) for Breast Cancer (BC) Radiation Therapy Planning (2005) (0)
Basic principles of radiotherapy in ophtalmic oncology (2009) (0)
1586P Assessment of side effects of radiation therapy in patients with COVID-19 treated for early-stage breast cancer (2021) (0)
28 European transfer of breast cancer treatment technique (1996) (0)
Inflammatory Breast Cancer: What Should Be the Locoregional Treatment after Primary Chemotherapy? (2009) (0)
Radiation Exposure of Cardiac Conduction Nodes During Breast Proton Therapy (2023) (0)
[Patient selection and early tolerance of whole breast irradiation according to the "Fast Forward" protocol: Preliminary results]. (2021) (0)
190 INVITED Partial breast irradiation–avalid option? (2007) (0)
2042 Does pregnancy influence breast cancer outcome in young women (1997) (0)
Breast preservation following primary chemotherapy or primary radiotherapy in large breast cancer: A randomized trial (1993) (0)
Radiation therapy after breast-conserving (2012) (0)
Long-Term Results of Post Mastectomy Conformal Electron Therapy Technique (PMERT) with Bolus in Comparison with Post Mastectomy Conformal Photon Therapy (PMPhRT) without Bolus in Non-Metastatic Breast Cancer Patients (2018) (0)
Simultaneous Integrated Boost in the Treatment of Breast Cancer: A Dosimetric Comparison of Helical Tomotherapy (HT) and Three-dimensional Conformal Radiotherapy (3D CRT) (2009) (0)
Effects of superoxide dismutase (SOD) on late radiofibrosis following conservative treatment for breast cancer: A clinical and laboratory study (1993) (0)
A multidisciplinary approach to boost the breast tumor bed in 8 phases (2008) (0)
PO-1229 Radiotherapy-based management of non-metastatic Inflammatory breast cancers: a retrospective study (2022) (0)
Abstract 3449: Impact ofBRCA2mutation in primary human triple negative breast cancer xenografts on the responses to ionizing radiation andin vivotumor growth after treatment (2012) (0)
Author’s reply to Dr. Baltoyiannis and colleagues’ letter (2008) (0)
EP-1254: Role of implantable venous devices in dose distribution: dosimetric and clinical considerations (2018) (0)
[Treatment of borderline lesions and non-infiltrating carcinoma]. (1990) (0)
Abstract P4-12-23: Institut Curie guidelines on breast target volume delineation for patients treated in lateral position (2020) (0)
Patterns of Locoregional Failure in Women With Early Stage Breast Cancer Treated by Whole Breast Radiation Therapy in the Lateral Isocentric Decubitus Position: Large-Scale Single Center Experience (2017) (0)
Dosimetric Findings and Acute Side Effects of Patients Treated in the Lateral Decubitus Position with Whole Breast Radiotherapy in Early-stage Breast Cancer (2011) (0)
P4-09-01: Identification of Poor Prognosis T1T2N0 Luminal ERBB2-ve Breast Carcinomas. (2011) (0)
Abstract P4-04-04: Polarity Abnormalities in Invasive Carcinomas of the Breast: Analysis of Invasive Micropapillary Carcinoma of the Breast (2010) (0)
Irradiation policy for the internal mammary chain in the EORTC trial 22922/10925 (2004) (0)
Abstract P1-10-01: Postmastectomy electron beams radiation therapy (PMERT) : long term results (2023) (0)
Rotational Intensity Modulated Radiation Therapy in Complex Adjuvant Breast and Nodes Irradiation (2015) (0)
Safety of hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: A multi-center comparative study (2019) (0)
247 Is exclusive radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy (2010) (0)
The higher local recurrence rate after breast conserving therapy in young patients explained by larger tumour size, incomplete excision at first attempt and smaller excision volume? (1998) (0)
OC-0934 Outcomes of the EORTC 22922/10925 randomised trial according to the technique for nodal irradiation (2022) (0)
Tamoxifene and hypofractionated radiotherapy for breast cancer in elderly women (1993) (0)
Early Breast Cancer (Stage I and II): Tailored Radiotherapy for Very Young Women (2006) (0)
[Biological, preclinical and clinical aspects of the association between radiation therapy and CDK4/6 inhibitors]. (2023) (0)
Abstract P1-15-04: Luminal B Lobular Carcinomas In Situ Have a Higher Risk of Relapse Compared to the Other Molecular Types of Lobular Carcinomas In Situ: Results from a Pilot Retrospective Single Institution Study (2010) (0)
525 Follow-up after breast cancer by primary care physicians in the Ile-de-France region (2010) (0)
Relapsed, Refractory, or Advanced Hodgkin Lymphoma: A Single-Center Experience. (2020) (0)
SU‐FF‐T‐446: Deciphering Electron Dose Distributions in Ophthalmologic Radiation Therapy (2009) (0)
EP-1180: Whole breast radiotherapy in Lateral Decubitus position : efficacy and toxicity (2017) (0)
Delayed reaction after adjuvant whole breast radiotherapy at the dose of 42.9 Gy in 13 fractions over 5 weeks: the need for rapid post irradiation clinical assessment and who are the patients at risk? (2009) (0)
Preliminary result of a mono-institutional, prospective study of skin and cardiac toxicities in breast cancer patients treated by concurrent adjuvant trastuzumab and radiotherapy involving in most cases the internal mammary chain. (2009) (0)
Delayed Early Reaction after Adjuvant Whole Breast Radiotherapy at the Dose of 42.9 Gy in 13 Fractions Over 5 Weeks: The Need of Rapid Post Irradiation Clinics (2008) (0)
Management of breast cancer in the elderly. (1995) (0)
Management of localized primary breast B-cell Non-Hodgkin's Lymphoma: Role of CNS prophylaxis (2004) (0)
O-9 ONCOPOOL – A European Database in 16,893 cases of breast cancer: comparison with SEER (2007) (0)
Abstract P4-12-12: Outcomes of exclusive radiation therapy for breast cancer in older women according to age and comorbidity status: An observational retrospective study (2020) (0)
P3-05-03: Transcriptomic Validation of Molecular Classification of Invasive Ductal Carcinoma Based on Immunohistochemical Markers and Grade. (2011) (0)
Breast radiotherapy in women with pectus excavatum (funnel chest): is the lateral decubitus technique an answer? — a dosimetric study (2006) (0)
Identification of three-genomic regions prognostic signature in small node-negative breast carcinomas. (2009) (0)
CT-Imaging Protocol for Heart Delineation in The Radiation Therapy Preparation Workflow (2012) (0)
Physical Rationale for Proton Therapy and Elements to Build a Clinical Center (2016) (0)
In reply to Drs. Munshi and Jalali (2006) (0)
[The role of radiotherapy in the treatment of breast cancers]. (1992) (0)
53 Local control related to Kerma rate in T2T3 breast cancers treated by external irradiation and brachytherapy (1996) (0)
Abstract P3-19-24: Long-term follow-up results of intensity modulated radiotherapy in early-stage breast cancer patients (2022) (0)
Abstract P4-12-32: Intensity modulated radiotherapy (IMRT) for breast and lymph node irradiation (2020) (0)
EP-1273 PRELIMINARY RESULTS OF HELICAL TOMOTHERAPY FOR SOFT TISSUE SARCOMA OF THE THIGH (2012) (0)
Impact on the cosmetic outcome of concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery: Differences between patient's and doctor's views. (2006) (0)
OC-0630 Olaparib combined with radiotherapy for TNBC: 1-year toxicity report of the RADIOPARP phase 1 trial (2021) (0)
307 oral RISK OF SECOND MALIGNANCIES (SM) AFTER BREAST CANCER (BC) TREATMENT AND THEIR RELATIONSHIP WITH THE ADJUVANT RADIOTHERAPY: LONG TERM RESULTS (2011) (0)
Preliminary Results of the Use of Helical Tomotherapy (HT) in Advanced Nonmelanoma Skin Cancers (2012) (0)
Tumour response to primary chemotherapy predicts breast conservation and survival (1993) (0)
Radiotherapy in early breast cancer: who does not need it? (2006) (0)
Concurrent Olaparib with Radiotherapy in Patients with Triple Negative Breast Cancer: Final Results of the RADIOPARP Phase 1 Trial (2022) (0)
EP-1316: The use of Helical Tomotherapy in early stage breast cancer: indications, tolerance, efficacy (2018) (0)
13 No Axillary Surgery in Breast Cancer (2012) (0)
The importance of patient's position in CT-scan based localization of the Internal Mammary Chain (IMC) and Supra Clavicular Nodes (SCN) for breast cancer (BC) radiation therapy planning (2006) (0)
186P Long-term follow-up results of intensity modulated radiotherapy in early-stage breast cancer patients (2021) (0)

This paper list is powered by the following services:

Alain Fourquet's Academic­Influence.com Rankings

Alain Fourquet's Degrees

Why Is Alain Fourquet Influential?

Alain Fourquet's Published Works

Published Works

Alain Fourquet's AcademicInfluence.com Rankings